Publicaciones en las que colabora con Albert Pahissa (17)

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  2. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687

2014

  1. Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation

    Transplant Infectious Disease, Vol. 16, Núm. 4, pp. 532-538

  2. Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: Study protocol for a multicenter, randomized, controlled clinical trial

    Trials, Vol. 15, Núm. 1

  3. Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): Experience from the RESITRA-REIPI cohort

    Transplant Infectious Disease, Vol. 16, Núm. 3, pp. 387-396

2013

  1. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis

    Clinical Infectious Diseases, Vol. 56, Núm. 9, pp. 1261-1268

2012

  1. Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: A prospective and multicentre cohort study

    Transplant International, Vol. 25, Núm. 12, pp. 1275-1281

  2. Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: Impact of viral and non-viral co-infection

    Clinical Microbiology and Infection, Vol. 18, Núm. 1, pp. 67-73

2011

  1. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients Recomendaciones GESITRA-SEIMC/REIPI para el manejo de la infección por citomegalovirus en pacientes trasplantados de órgano sólido

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 10, pp. 735-758

2008

  1. Donor infection and transmission to the recipient of a solid allograft

    American Journal of Transplantation, Vol. 8, Núm. 11, pp. 2420-2425

  2. Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients

    Clinical Infectious Diseases, Vol. 46, Núm. 1, pp. 20-27

2007

  1. Brief communication: Treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone

    Annals of Internal Medicine, Vol. 146, Núm. 8, pp. 574-579

2005

  1. Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus in transplanted patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 7, pp. 424-437

  2. Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study

    Clinical Infectious Diseases, Vol. 41, Núm. 1, pp. 52-59

2004

  1. Trasplante hepático en patientes con infección por el VIH: Una realidad en el año 2004

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 9, pp. 529-538

2002

  1. Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults

    Clinical Infectious Diseases, Vol. 35, Núm. 2, pp. 130-139